Long Term Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for MS

Study Title
A Study to Evaluate the Long Term Safety and Effectiveness of Novantrone Therapy Followed by Copaxone Treatment for Multiple Sclerosis
Teva Identifier
PM025
ClinicalTrials.gov Identifier
NCT00203086
Study Status
Completed
Trial Condition(s)
Relapsing Remitting Multiple Sclerosis
Interventions
Drug: Copaxoneֲ®

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
20 Years to 57 Years
Trial Duration
10/01/2005 - 12/01/2009

Study Type

Observational